Skip to main content

Advertisement

SpringerLink
Log in

Malignant lymphomas and autoimmunity—a single center experience from Hungary

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Autoimmune diseases and malignant lymphomas have numerous similarities in their etiology and pathogenesis. Patients with autoimmune disorders have increased risk to develop non-Hodgkin's lymphomas, yet little is known about the occurrence of autoimmune features within lymphoma patients. Our aim was to examine the prevalence of autoimmune diseases among patients with non-Hodgkin's (NHL) and Hodgkin's lymphoma (HL). We reviewed 352 patients' charts with malignant lymphomas to assess the rate of associated autoimmune diseases. Of 231 NHL patients, 30 (12.9%) had autoimmune disorders, while there were 11 patients who suffered from more than one disease entity. It was Sjögren's syndrome that occurred in the largest number (eight cases), other frequent entities were undifferentiated connective tissue disease (seven), thyroiditis (six), rheumatoid arthritis (four), and systemic vasculitis (four). The female/male ratio was significantly different between patients with or without autoimmune diseases, while no other clinical features differed significantly between the two groups. Ten patients (33.3%) were initially diagnosed with lymphoma, 13 (43.3%) of them had already been diagnosed with autoimmune disease at the time of lymphoma occurrence. Six patients (20%) with previously diagnosed immunological disorder developed new autoimmune condition after the treatment of lymphoma. Lymphoma and autoimmune disease occurred simultaneously in one patient. Among the 121 HL patients, 14 (11.5%) had associated autoimmune disease. Ten patients developed thyroiditis after the lymphoma treatment, two had immune thrombocytopenia, and one had autoimmune hemolytic anemia. One female patient was diagnosed with systemic sclerosis 10 years before the onset of HL. Our results highlight that an increased risk for the development of autoimmune diseases should be considered in patients both with NHL and HL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goodnow CC (2007) Multistep pathogenesis of autoimmune disease. Cell 130:25–35

    Article  PubMed  CAS  Google Scholar 

  2. Mackay IR, Rose NR (2009) Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol 2:793–795

    Article  Google Scholar 

  3. Goldin LR, Landgren O (2009) Autoimmunity and lymphomagenesis. Int J Cancer 124:1497–1502

    Article  PubMed  CAS  Google Scholar 

  4. Fleisher TA (2008) The autoimmune lymphoproliferative syndrome: the experiment of nature involving lymphocyte apoptosis. Immunol Res 40:87–92

    Article  PubMed  Google Scholar 

  5. Hansen A, Lipsky PE, Dorner T (2007) B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 3:561–569

    Article  PubMed  CAS  Google Scholar 

  6. Mackay F, Silveira PA, Brink R (2007) B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol 19:327–336

    Article  PubMed  CAS  Google Scholar 

  7. Novak AJ, Grote DM, Stenson M et al (2004) Expression of BLys and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 104:2247–2253

    Article  PubMed  CAS  Google Scholar 

  8. Hagiwara E, Klinman DM (1996) Abnormalities in cytokine production and responsiveness in autoimmune disease. In: Snapper CM (ed) Cytokine regulation of humoral immunity. Wiley, Chichester, pp 409–430

    Google Scholar 

  9. Baráth S, Aleksza M, Keresztes K et al (2006) Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma. Acta Haematol 116:181–185

    Article  PubMed  Google Scholar 

  10. Baráth S, Aleksza M, Tarr T et al (2007) Measurement of natural (CD4+CD25high) and inducible (CD4+IL10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus 16:489–496

    Article  PubMed  Google Scholar 

  11. Engels AE (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:401–404

    Article  PubMed  CAS  Google Scholar 

  12. Martin DN, Mikhail IS, Landgren O (2009) Autoimmunity and hematologic malignancies: associations and mechanisms. Leuk Lymphoma 50:541–550

    Article  PubMed  Google Scholar 

  13. Zhang Y, Holford TR, Leaderer B et al (2004) Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States Women. Cancer Causes Control 15:419–428

    Article  PubMed  Google Scholar 

  14. Smedby KE, Vajdic CM, Falster M et al (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4028–4039

    Google Scholar 

  15. Voulgarelis M, Skopouli FN (2007) Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol 32:265–274

    Article  PubMed  CAS  Google Scholar 

  16. Bjornadal L, Lofstrom B, Yin L et al (2002) Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 31:66–71

    Article  PubMed  Google Scholar 

  17. Askling J, Fored CM, Baecklund E et al (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64:1414–1420

    Article  PubMed  CAS  Google Scholar 

  18. Smedby KE, Askling J, Mariette X et al (2008) Autoimmune and inflammatory disorders and risk of malignant lymphomas—an update. J Int Med 264:514–527

    Article  CAS  Google Scholar 

  19. Landgren A, Gridley G, Check D et al (2007) Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol 139:791–798

    Article  PubMed  Google Scholar 

  20. Smedby KE, Hjalgrim H, Askling J et al (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51–60

    Article  PubMed  Google Scholar 

  21. Anderson LA, Gadalla S, Morton LM et al (2009) Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125:398–405

    Article  PubMed  CAS  Google Scholar 

  22. Bernatsky S, Ramsey-Goldman R, Isenberg D et al (2007) Hodgkin's lymphoma in systemic lupus erythematosus. Rheumatology (Oxford) 46:830–832

    Article  CAS  Google Scholar 

  23. Theander E, Jacobsson LT (2008) Relationship of Sjögren's syndrome to other to other connective tissue and autoimmune diseases. Rheum Dis Clin North Am 34:935–947

    Article  PubMed  Google Scholar 

  24. Gergely L, Danko A, Csipo I et al (2005) Antibodies against extractable nuclear antigen (ENA) in non-Hodgkin lymphoma patients may be a non-specific marker of apoptosis. J Scan Immunol 61:343–347

    Article  CAS  Google Scholar 

  25. Varoczy L, Gergely L, Zeher M et al (2002) Malignant lymphoma-associated autoimmune diseases—a descriptive epidemiological study. Rheumatol Int 22:233–237

    Article  PubMed  Google Scholar 

  26. Illes A, Biro E, Miltenyi Z et al (2002) Hypothyreoidism and thyroiditis after therapy for Hodgkin's disease. Acta Haematol 109:11–17

    Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Third Department of Medicine, Medical and Health Science Center, University of Debrecen, Móricz Zs. krt. 22, 4032, Debrecen, Hungary

    László Váróczy, Edit Páyer, Zsuzsanna Kádár, Lajos Gergely, Zsófia Miltényi, Ferenc Magyari & Árpád Illés

  2. Instititute of Immunology, Rikshospitalet, University of Oslo, Sognsvannsveien 20, 0027, Oslo, Norway

    Péter Szodoray

Authors
  1. László Váróczy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edit Páyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zsuzsanna Kádár
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lajos Gergely
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zsófia Miltényi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ferenc Magyari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Péter Szodoray
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Árpád Illés
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to László Váróczy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Váróczy, L., Páyer, E., Kádár, Z. et al. Malignant lymphomas and autoimmunity—a single center experience from Hungary. Clin Rheumatol 31, 219–224 (2012). https://doi.org/10.1007/s10067-011-1807-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1807-1

Keywords

Search

Navigation